Treatment with Growth Hormone Receptor Antagonist in Acromegaly: Effect on Cardiac Structure and Performance | Zendy

Rosario Pivonello | Zendy; Maurizio Galderisi | Zendy; Renata S. Auriemma | Zendy; Maria Cristina De Martino | Zendy; Mariano Galdiero | Zendy; Antonio Ciccarelli | Zendy; Arcangelo D’Errico | Zendy; IONE A. KOURIDES | Zendy; Pia Burman | Zendy; Gaetano Lombardi | Zendy; Annamaria Colao | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Treatment with Growth Hormone Receptor Antagonist in Acromegaly: Effect on Cardiac Structure and Performance

Author(s) -

Rosario Pivonello,

Maurizio Galderisi,

Renata S. Auriemma,

Maria Cristina De Martino,

Mariano Galdiero,

Antonio Ciccarelli,

Arcangelo D’Errico,

IONE A. KOURIDES,

Pia Burman,

Gaetano Lombardi,

Annamaria Colao

Publication year - 2006

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2006-1587

Subject(s) - pegvisomant , medicine , acromegaly , ejection fraction , ventricle , diastole , isovolumic relaxation time , cardiology , doppler echocardiography , endocrinology , cardiac function curve , left ventricular hypertrophy , hormone , heart failure , blood pressure , growth hormone

The aim of the current study was to evaluate the effect of short-term (6 months) and long-term (18 months) treatment with pegvisomant on cardiac structure and performance in patients with acromegaly.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research